195 related articles for article (PubMed ID: 31639245)
21. Planifier une grossesse chez une patiente avec un psoriasis.
Brenaut É
Eur J Dermatol; 2020 Oct; 30(S1):18-24. PubMed ID: 33242005
[TBL] [Abstract][Full Text] [Related]
22. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
Matro R; Martin CF; Wolf D; Shah SA; Mahadevan U
Gastroenterology; 2018 Sep; 155(3):696-704. PubMed ID: 29857090
[TBL] [Abstract][Full Text] [Related]
23. Update on TNF Inhibitors.
Kerdel FA
Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S67-70. PubMed ID: 27526035
[TBL] [Abstract][Full Text] [Related]
24. Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials.
Loftus EV; Colombel JF; Schreiber S; Randall CW; Regueiro M; Ali T; Arendt C; Coarse J; Spearman M; Kosutic G
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1753-1762. PubMed ID: 27464588
[TBL] [Abstract][Full Text] [Related]
25. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
[TBL] [Abstract][Full Text] [Related]
26. Exposure to biological therapies during conception and pregnancy: a systematic review.
Pottinger E; Woolf RT; Exton LS; Burden AD; Nelson-Piercy C; Smith CH
Br J Dermatol; 2018 Jan; 178(1):95-102. PubMed ID: 28718898
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of treatment with anti-tumor necrosis factor-α drugs for severe impetigo herpetiformis.
Fukushima H; Iwata Y; Arima M; Tanaka Y; Sugiura K
J Dermatol; 2021 Feb; 48(2):207-210. PubMed ID: 33035362
[TBL] [Abstract][Full Text] [Related]
28. Considering a Biologic: What's a Clinician to Do? Management of Biologics in Surgery, Vaccinations, and Cancer.
Jin A; Zaladonis AG; Hsu S
Skinmed; 2021; 19(1):17-19. PubMed ID: 33658108
[TBL] [Abstract][Full Text] [Related]
29. Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
Reich K; Mrowietz U; Radtke MA; Thaci D; Rustenbach SJ; Spehr C; Augustin M
Arch Dermatol Res; 2015 Dec; 307(10):875-83. PubMed ID: 26358263
[TBL] [Abstract][Full Text] [Related]
30. Treating psoriasis patients with biologic agents.
Pariser DM
Manag Care; 2003 Dec; 12(12):50-7; discussion 57-9; quiz 60-2. PubMed ID: 14723104
[No Abstract] [Full Text] [Related]
31. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
[TBL] [Abstract][Full Text] [Related]
32. Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors.
Tragiannidis A; Kyriakidis I; Zündorf I; Groll AH
Mycoses; 2017 Apr; 60(4):222-229. PubMed ID: 27766695
[TBL] [Abstract][Full Text] [Related]
33. Does therapy with biological drugs influence COVID-19 infection? Observational monocentric prevalence study on the clinical and epidemiological data of psoriatic patients treated with biological drugs or with topical drugs alone.
Brazzelli V; Isoletta E; Barak O; Barruscotti S; Vassallo C; Giorgini C; Michelerio A; Tomasini CF; Musella V; Klersy C
Dermatol Ther; 2020 Nov; 33(6):e14516. PubMed ID: 33169500
[TBL] [Abstract][Full Text] [Related]
34. Biologics in pediatric psoriasis - efficacy and safety.
Dogra S; Mahajan R
Expert Opin Drug Saf; 2018 Jan; 17(1):9-16. PubMed ID: 29022425
[TBL] [Abstract][Full Text] [Related]
35. The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis.
D'Adamio S; Silvaggio D; Lombardo P; Bianchi L; Talamonti M; Galluzzo M
Expert Opin Drug Saf; 2019 Nov; 18(11):1031-1041. PubMed ID: 31479282
[No Abstract] [Full Text] [Related]
36. Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab.
Galluzzo M; D'Adamio S; Bianchi L; Talamonti M
J Dermatolog Treat; 2019 Feb; 30(1):40-44. PubMed ID: 29676599
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.
Ovejero-Benito MC; Muñoz-Aceituno E; Reolid A; Saiz-Rodríguez M; Abad-Santos F; Daudén E
Am J Clin Dermatol; 2018 Apr; 19(2):209-222. PubMed ID: 28921458
[TBL] [Abstract][Full Text] [Related]
38. Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.
Medina C; Carretero G; Ferrandiz C; Dauden E; Vanaclocha F; Gómez-García FJ; Herrera-Ceballos E; De la Cueva-Dobao P; Belinchón I; Sánchez-Carazo JL; Alsina M; López-Estebaranz JL; Ferrán M; Carrascosa JM; Torrado R; Argila D; Rivera R; Jiménez-Puya R; García-Doval I;
J Eur Acad Dermatol Venereol; 2015 May; 29(5):858-64. PubMed ID: 25185962
[TBL] [Abstract][Full Text] [Related]
39. Psoriasis and COVID-19: A narrative review with treatment considerations.
Elmas ÖF; Demirbaş A; Kutlu Ö; Bağcıer F; Metin MS; Özyurt K; Akdeniz N; Atasoy M; Türsen Ü; Lotti T
Dermatol Ther; 2020 Nov; 33(6):e13858. PubMed ID: 32686245
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
